VISP and INVEST.
Liebson
Philip R
PR
Section of Cardiology, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA. pliebson@rush.edu
D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D006710:Homocysteine / Q000097:blood; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D007211:Indoles / Q000627:therapeutic use*; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D020521:Stroke / Q000517:prevention & control*; D014700:Verapamil / Q000627:therapeutic use*; D014815:Vitamins / Q000627:therapeutic use*
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D007211:Indoles; D014815:Vitamins; D006710:Homocysteine; C052035:trandolapril; D014700:Verapamil